Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Aurobindo Pharma Limited
Pazopanib
Listed by AvKARE
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Pazopanib Hydrochloride 200 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 42291-939 |
| FDA application | ANDA217517 |
| RxNorm concept | 867502 |
| Package sizes listed | 1 |
| Marketed since | April 2024 |
Other products containing Pazopanib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
SUN PHARMACEUTICAL INDUSTRIES, INC.
Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals, Inc.
pazopanib
pazopanib hydrochloride
- Strength
- 400 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Torrent Pharmaceuticals Limited
pazopanib
pazopanib hydrochloride
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Novugen Pharma (USA) LLC.
Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Golden State Medical Supply, Inc.
Pazopanib
- Strength
- 200 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Apotex Corp.
VOTRIENT
pazopanib hydrochloride
- Strength
- 200 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Novartis Pharmaceuticals Corporation
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.